Aims and Scope
Annals of Thoracic and Cardiovascular Surgery is an international, peer-reviewed, open access journal that publishes significant and novel contributions in thoracic surgery. The journal, which is supported by the Japanese Association for Coronary Artery Surgery, aims to facilitate the communication and progress of thoracic surgery worldwide.
Welcome Essay from the Editor in Chief
Annals of Thoracic and Cardiovascular Surgery was first published in 1995 and is now in its 28th year of publication.
This journal is collated into issues six times a year and covers the fields of cardiovascular, respiratory, and esophageal surgery.
Instructions to Authors
Annals of Thoracic and Cardiovascular Surgery supplies comprehensive and clear Instructions to Authors, which offer guidance on article types and format, journal policies, and how to submit manuscripts.
The journal welcomes submissions from around the world.
Journal data
Online ISSN: 2186-1005
Print ISSN: 1341-1098
ISSN-L: 1341-1098
Online Journal
Metrics
Turnaround times
Median submission to first decision: 15 days
Median acceptance to publication: 103 days
Citation indices
Impact Factor (2023): 1.1
Scimago Journal Ranking: 0.49(Q2)
Featured ArticlesView more articles >
Review ArticleFebruary 20, 2022
Objective: The purpose of this article was to assess the benefit of perioperative administration of the intravenous beta-blocker landiolol hydrochloride in preventing atrial fibrillation (AF) after cardiothoracic surgery. Methods: We performed a systematic search in PubMed, Web of Science, CNKI, and OVID to identify randomized controlled trials (RCTs) and cohorts up to January 2021. Data regarding postoperative atrial fibrillation (POAF) and safety outcomes were extracted. Odds ratios (ORs) with 95% confidence intervals (CIs) were determined using the Mantel–Haenszel method. Meanwhile, subgroup analyses were conducted according to surgery type including lung cancer surgery, esophageal cancer surgery, and cardiac surgery.
Original ArticleDecember 20, 2022
Purpose: The best treatment strategy for primary spontaneous pneumothorax is controversial and varies widely in practice. Methods: Literatures were searched from databases till 24 August 2021. A Bayesian network meta-analysis was conducted to compare the outcomes of various treatments with the following endpoints: recurrence rate, postoperative chest tube duration, postoperative air leakage duration, length of hospital stay, and complications rate.
Original ArticleAugust 20, 2023
Sex Differences in the Outcomes of Degenerative Mitral Valve Repair
Purpose: This study explored the sex differences in the outcomes of degenerative mitral valve repair (MVr). Methods: From 2010 to 2019, 1069 patients who underwent MVr due to degenerative mitral disease at Beijing Anzhen Hospital were analyzed. The average patient follow-up was 5.1 years (interquartile range: 5–7 years). The primary endpoint was overall survival. Secondary endpoints were freedom from reoperation and recurrent mitral regurgitation. A propensity-matched analysis was used to compare the outcomes of males and females.
Original ArticleJune 20, 2022
Hemoadsorption of Rivaroxaban and Ticagrelor during Acute Type A Aortic Dissection Operations
Objective: To analyze the results of hemoadsorption in patients with cardiac surgery to thoracic aortic surgery, who had been loaded beforehand with either Factor Xa inhibitor rivaroxaban or P2Y12 receptor antagonist ticagrelor. Methods: We investigated 21 of 171 consecutive patients (median age 71 [interquartile range 62, 76] years) who underwent emergency cardiac operations for acute type A aortic dissection between 2014 and 2020. These patients were pretreated with rivaroxaban (n = 9) or ticagrelor (n = 12). In ten of 21 cases (since 2017), we installed a hemoadsorber into the heart–lung machine and compared the results to eleven patients done without hemoadsorber before that time.
About the Society
This journal is an associate journal of the Japanese Association for Coronary Artery Surgery.
The Japanese Society of Coronary Artery Surgery was established in 1996 and has a history of more than 20 years. It currently has about 800 members, making it one of the few societies in the world that specialize in coronary artery surgery.
This society contributes to the sustainable development of thoracic surgery by providing a platform for researchers in coronary surgery to disseminate their research results.
Contact details
Editorial Office
Annals of Thoracic and Cardiovascular Surgery
Email: atcs-edit[at]je.bunken.co.jp (Please replace [at] with @)